Plantago major L. in Erosive gastroduodenitis
Phase 3
Recruiting
- Conditions
- Erosive gastroduodenitis.Gastroduodenitis, unspecifiedK29.9
- Registration Number
- IRCT20190722044307N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Erosive gastroduodenitis in endoscopy
Negative Helicobacter pylori Test
Written informed consent
Exclusion Criteria
pregnancy and lactation
cardiovascular disease
epilepsy
anticoagulant medications
use of a research drug in the past 30 day
any factor to reduce patient compliance and tolerance, such as alcohol and drug abuse
The existence of a severe illness that make performing endoscopy for them dangerous
severe bleeding
Coagulation Disorders
Zollinger Ellison syndrome
lung disease
Malignancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of gastrointestinal symptoms. Timepoint: At the beginning of the study (before the intervention) and at the end of the study (28 days after the intervention). Method of measurement: A questionnaire derived from ROME III and Visual Analogue Scale questionnaire.;Frequency of symptoms in the week. Timepoint: At the beginning of the study (before the intervention) and at the end of the study (28 days after the intervention). Method of measurement: A questionnaire derived from ROME III.
- Secondary Outcome Measures
Name Time Method Treatment Adverse reaction. Timepoint: End of the study. Method of measurement: Ask from patient.;Treatment satisfaction. Timepoint: End of the study. Method of measurement: Questionnair.